Amicus Therapeutics (FOLD)
(Real Time Quote from BATS)
$9.57 USD
0.00 (0.00%)
Updated May 20, 2024 09:40 AM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.08 |
EPS Last Quarter | -0.02 |
Last EPS Surprise | 66.67% |
ABR | 1.36 |
Earnings ESP
|
-9.57% |
---|---|
Current Year | -0.19 |
Next Year | 0.22 |
EPS (TTM) | -0.35 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 121.61M | 134.43M | 509.40M | 645.55M |
# of Estimates | 5 | 5 | 3 | 5 |
High Estimate | 123.69M | 137.85M | 510.29M | 689.27M |
Low Estimate | 119.40M | 132.78M | 507.70M | 601.11M |
Year ago Sales | 94.50M | 103.50M | 399.36M | 509.40M |
Year over Year Growth Est. | 28.68% | 29.88% | 27.55% | 26.73% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.08 | -0.02 | -0.19 | 0.22 |
# of Estimates | 6 | 4 | 7 | 6 |
Most Recent Consensus | -0.07 | -0.04 | -0.28 | 0.20 |
High Estimate | -0.04 | 0.01 | 0.01 | 0.53 |
Low Estimate | -0.16 | -0.04 | -0.31 | 0.03 |
Year ago EPS | -0.15 | -0.07 | -0.51 | -0.19 |
Year over Year Growth Est. | 46.67% | 71.43% | 62.75% | 217.54% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 1 | 1 |
Down Last 30 Days | 3 | 3 | 6 | 4 |
Down Last 60 Days | 3 | 3 | 7 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.08 | -0.02 | -0.19 | 0.22 |
7 Days Ago | -0.06 | -0.02 | -0.17 | 0.24 |
30 Days Ago | -0.02 | 0.02 | 0.01 | 0.34 |
60 Days Ago | -0.02 | 0.02 | 0.03 | 0.36 |
90 Days Ago | -0.04 | 0.01 | 0.06 | 0.41 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.08 | -0.02 | -0.21 | 0.23 |
Zacks Consensus Estimate | -0.08 | -0.02 | -0.19 | 0.22 |
Earnings ESP | -9.57% | -55.55% | -10.53% | 1.87% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.02 | -0.11 | -0.07 | -0.15 | NA |
Estimate | -0.06 | -0.06 | -0.08 | -0.12 | NA |
Difference | 0.04 | -0.05 | 0.01 | -0.03 | -0.01 |
Surprise | 66.67% | -83.33% | 12.50% | -25.00% | -7.29% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more